Catalyst Pharmaceuticals, Inc.
NASDAQ:CPRX · NASDAQ Capital Market
-$0.01 today
Vol 2.87M · Avg 2.17M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+41.86%
Period High
$31.40
Period Low
$19.13
Latest
$31.38
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Cidara Therapeutics, Inc.
CDTX
$5.61B
Scholar Rock Holding Corporation
NASDAQ:SRRK
$5.60B
Apellis Pharmaceuticals, Inc.
APLS
$5.25B
Kiniksa Pharmaceuticals, Ltd.
NASDAQ:KNSA
$4.14B
Beam Therapeutics Inc.
NASDAQ:BEAM
$3.40B
IDEAYA Biosciences, Inc.
NASDAQ:IDYA
$2.92B
Adaptive Biotechnologies Corporation
NASDAQ:ADPT
$2.79B
Agios Pharmaceuticals, Inc.
NASDAQ:AGIO
$2.00B
Mineralys Therapeutics, Inc.
NASDAQ:MLYS
$1.69B
Recursion Pharmaceuticals, Inc.
NASDAQ:RXRX
$1.40B
What is the latest CPRX filing?
The latest filing shown is DEFM14A dated Jun 8, 2026.
How many recent filings does CPRX have?
Intrinsic Alpha currently shows 20 recent filings for CPRX.
Explore More
Continue the stock analysis
Jump to another research area for this company.